HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuichi Kawata Selected Research

satralizumab

1/2020Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
11/2019Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuichi Kawata Research Topics

Disease

2Neuromyelitis Optica (Devic's Disease)
01/2020 - 11/2019
1Rheumatoid Arthritis
03/2023
1Pruritus (Itching)
08/2021
1Osteoporosis
11/2020
1Fatigue
11/2019
1Autoimmune Diseases (Autoimmune Disease)
11/2019
1Chronic Disease (Chronic Diseases)
11/2019
1Pain (Aches)
11/2019

Drug/Important Bio-Agent (IBA)

2Immunosuppressive Agents (Immunosuppressants)IBA
01/2020 - 11/2019
2satralizumabIBA
01/2020 - 11/2019
1Antirheumatic Agents (DMARD)IBA
03/2023
1nemolizumabIBA
08/2021
1eldecalcitol (ED 71)IBA
11/2020
1Alendronate (Alendronate Sodium)FDA LinkGeneric
11/2020
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1AutoantibodiesIBA
11/2019

Therapy/Procedure

2Therapeutics
01/2020 - 11/2019
1Renal Dialysis (Hemodialysis)
08/2021